title: Disparate results in studies of adalimumab in the treatment of hidradenitis suppurativa: comment on the article by Amano et al.
authors: Ricardo
authors: R
authors: Blanco
authors: Marcos A
authors: MA
authors: González-López
authors: María Carmen
authors: MC
authors: González-Vela
authors: Héctor
authors: H
authors: Fernández-Llaca
authors: Miguel A
authors: MA
authors: González-Gay
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D005260:Female; D017497:Hidradenitis Suppurativa / Q000188:drug therapy*; D006801:Humans; D008297:Male
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal